Literature DB >> 7814558

Analysis of hepatitis C virus isolates among healthy blood donors and drug addicts in Chiang Mai, Thailand.

C Apichartpiyakul1, C Chittivudikarn, H Miyajima, M Homma, H Hotta.   

Abstract

Hepatitis C virus (HCV) isolates obtained from 25 anti-HCV antibody-positive healthy blood donors and 29 drug addicts in Chiang Mai, Thailand, were analyzed. HCV RNA was detected in 23 blood donor samples (92%) and 24 drug addict blood samples (83%) by PCR for a portion of the NS5 region. Subtype analysis revealed that HCV type 3a (HCV-3a) was the prevailing subtype (30%), which was followed in prevalence by HCV-1a (21%), -1b (13%), -3b (13%), and -6a (2%). Six (13%) of the 47 isolates showed low sequence similarities with known types and subtypes. The sequence variants could be grouped into four branches in a molecular evolutionary phylogenetic tree.

Entities:  

Mesh:

Year:  1994        PMID: 7814558      PMCID: PMC263982          DOI: 10.1128/jcm.32.9.2276-2279.1994

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  22 in total

1.  A new type of hepatitis C virus in patients in Thailand.

Authors:  S Mori; N Kato; A Yagyu; T Tanaka; Y Ikeda; B Petchclai; P Chiewsilp; T Kurimura; K Shimotohno
Journal:  Biochem Biophys Res Commun       Date:  1992-02-28       Impact factor: 3.575

2.  Severity of liver disease with different hepatitis C viral clones.

Authors:  G Pozzato; M Moretti; F Franzin; L S Crocè; C Tiribelli; T Masayu; S Kaneko; M Unoura; K Kobayashi
Journal:  Lancet       Date:  1991-08-24       Impact factor: 79.321

3.  Distribution of plural HCV types in Japan.

Authors:  N Kato; Y Ootsuyama; S Ohkoshi; T Nakazawa; S Mori; M Hijikata; K Shimotohno
Journal:  Biochem Biophys Res Commun       Date:  1991-11-27       Impact factor: 3.575

Review 4.  Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease.

Authors:  M Houghton; A Weiner; J Han; G Kuo; Q L Choo
Journal:  Hepatology       Date:  1991-08       Impact factor: 17.425

5.  Nucleotide sequence of the genomic RNA of hepatitis C virus isolated from a human carrier: comparison with reported isolates for conserved and divergent regions.

Authors:  H Okamoto; S Okada; Y Sugiyama; K Kurai; H Iizuka; A Machida; Y Miyakawa; M Mayumi
Journal:  J Gen Virol       Date:  1991-11       Impact factor: 3.891

6.  Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis.

Authors:  N Kato; M Hijikata; Y Ootsuyama; M Nakagawa; S Ohkoshi; T Sugimura; K Shimotohno
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

7.  Genetic organization and diversity of the hepatitis C virus.

Authors:  Q L Choo; K H Richman; J H Han; K Berger; C Lee; C Dong; C Gallegos; D Coit; R Medina-Selby; P J Barr
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

8.  Identification of hepatitis C virus subtype 3b (HCV-3b) among Japanese patients with liver diseases using highly efficient primers for reverse transcription-polymerase chain reaction.

Authors:  H Doi; S Yoon; M Homma; H Hotta
Journal:  Microbiol Immunol       Date:  1994       Impact factor: 1.955

9.  Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources.

Authors:  H Okamoto; Y Sugiyama; S Okada; K Kurai; Y Akahane; Y Sugai; T Tanaka; K Sato; F Tsuda; Y Miyakawa
Journal:  J Gen Virol       Date:  1992-03       Impact factor: 3.891

10.  Primary structural comparison of RNA-dependent polymerases from plant, animal and bacterial viruses.

Authors:  G Kamer; P Argos
Journal:  Nucleic Acids Res       Date:  1984-09-25       Impact factor: 16.971

View more
  9 in total

1.  Prevalence of GB virus C/Hepatitis G virus infection among various populations in Surabaya, Indonesia, and identification of novel groups of sequence variants.

Authors:  R Handajani; M I Lusida; P Suryohudoyo; P Adi; P B Setiawan; C A Nidom; R Soemarto; Y Katayama; M Fujii; H Hotta
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Predominance of hepatitis C virus genotype 1b in Bulgaria.

Authors:  A Andonov; P Teoharov; S Bakalova
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-06       Impact factor: 3.267

3.  Nuclear localization of the NS3 protein of hepatitis C virus and factors affecting the localization.

Authors:  S Muramatsu; S Ishido; T Fujita; M Itoh; H Hotta
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

4.  Hepatitis C virus (HCV) subtype prevalence in Chiang Mai, Thailand, and identification of novel subtypes of HCV major type 6.

Authors:  H Doi; C Apichartpiyakul; K I Ohba; M Mizokami; H Hotta
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

5.  Genotypic distribution of hepatitis C virus in different regions of Thailand.

Authors:  D Kanistanon; M Neelamek; T Dharakul; S Songsivilai
Journal:  J Clin Microbiol       Date:  1997-07       Impact factor: 5.948

6.  Survey of type 6 group variants of hepatitis C virus in Southeast Asia by using a core-based genotyping assay.

Authors:  J Mellor; E A Walsh; L E Prescott; L M Jarvis; F Davidson; P L Yap; P Simmonds
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

7.  Differential prevalence of hepatitis C virus subtypes in healthy blood donors, patients on maintenance hemodialysis, and patients with hepatocellular carcinoma in Surabaya, Indonesia.

Authors:  R Handajani; M I Lusida; S Darmadi; P Adi; S Ishido; Y Katayama; H Hotta
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

8.  Comparative sequence analysis of the core protein and its frameshift product, the F protein, of hepatitis C virus subtype 1b strains obtained from patients with and without hepatocellular carcinoma.

Authors:  Satoshi Ogata; Motoko Nagano-Fujii; Yonson Ku; Seitetsu Yoon; Hak Hotta
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

9.  High rate of seronegative HCV infection in HIV-positive patients.

Authors:  Takako Utsumi; Lindawati Alimsardjono; Mochamad Amin; Myrna Adianti; Yoshihiko Yano; Yoshitake Hayashi; Hak Hotta; Maria Inge Lusida
Journal:  Biomed Rep       Date:  2013-10-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.